Concord Drugs Ltd Receives Significant Purchase Orders Worth Approximately ₹ 14.71 Crores

Concord Drugs Ltd has announced that it has received significant purchase orders from various entities for the supply of its products during December 2025. The total value of these orders is approximately ₹ 14,70,52,192.59 (~ 14.71 Crores), which is expected to have a positive impact on the company's business and operations. The orders are from Tamil Nadu Medical Services Corporation Ltd (TNMSC), Directorate General of Health Services (DGHS), Government Medical Stores Depots, and Telangana State Infrastructure (TGMSIDC) And Other Entities Medical Development Services & Corporation of, for the supply of various pharmaceutical products. The orders are not related party transactions and are expected to be executed in the next 45 to 60 days.